Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0L2CG
|
||||
| Former ID |
DNC012310
|
||||
| Drug Name |
1-Benzyl-3-thiazol-2-yl-thiourea
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C11H11N3S2
|
||||
| Canonical SMILES |
C1=CC=C(C=C1)CNC(=S)NC2=NC=CS2
|
||||
| InChI |
1S/C11H11N3S2/c15-10(14-11-12-6-7-16-11)13-8-9-4-2-1-3-5-9/h1-7H,8H2,(H2,12,13,14,15)
|
||||
| InChIKey |
PDHMEDMWKUZUAB-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | HIV-1 reverse transcriptase | Target Info | Inhibitor | [1] | |
| References | |||||
| REF 1 | J Med Chem. 1995 Dec 8;38(25):4929-36.Phenethylthiazolethiourea (PETT) compounds, a new class of HIV-1 reverse transcriptase inhibitors. 1. Synthesis and basic structure-activity relationship studiesof PETT analogs. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.